Deal strengthens ContextVision’s position in the high-end, global MRI market
Stockholm, Sweden – April 8, 2015 – ContextVision, the leading provider of medical image processing software, has signed an agreement for yet another long-term contract with a major MRI company in the high-end market segment. This contract strengthens ContextVision’s position in the MRI sector as the company gains global MRI market-share.
Image quality is required for clinical accuracy, however it is still a challenge for MRI manufacturers around the world. This new customer will upgrade their future range of products with GOPView® MRI2Plus to achieve the best image quality. GOPView MRI2Plus provides higher contrast between white and gray matter in brain scans, which is particularly challenging in MRI. It uses advanced inhomogeneity compensation to obtain a homogeneous intensity throughout the whole image for better image quality. Additionally, GOPView MRI2Plus is optimized for high field units and provides excellent noise reduction and soft tissue differentiation.
“I’m very pleased to have signed yet another long-term contract with this major MRI company,” shared Fredrik Palm, Vice President – OEM Business, ContextVision. “They appreciate the value that we bring to their business and rely on us as a future-proof image enhancement partner. We are very happy to help our customers provide an excellent product that helps the clinicians in their daily work when reading MRI images.”
ContextVision’s medical imaging technology is at the forefront of the imaging industry, allowing OEMs to deliver excellent image quality to the market. This in turn puts powerful technology in the hands of clinicians that will allow them to make more accurate and faster diagnoses for patients. With MRI expertise and proprietary technology, ContextVision is the ultimate imaging partner for today and the future.
ContextVision’s technology provides doctors with improved images, which are crucial for accurate diagnosis and treatment. ContextVision is the industry leader in medical imaging analysis and enhancement software, with more than 150,000 installations worldwide through its OEM customers. The company started out as an industry pioneer more than 30 years ago, and is today developing the next generation of medical imaging software for 2D/3D/4D ultrasound, MRI, X-Ray, mammography and CT. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV.